NetworkNewsBreaks – PreveCeutical Medical Inc.
Post# of 77
(Total Views: 117)
Posted On: 03/09/2018 8:23:07 PM
NetworkNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Proprietary Sol-gel Formulations May Significantly Improve Bioavailability
Health sciences company PreveCeutical Medical (PRVCF) is engineering a unique Sol-gel CBD-based technology delivery platform to provide direct, controlled pharmacological drug release. This technology could provide a clinical benefit for patients seeking relief for multiple medical indications including pain, inflammation, seizures and neurological disorders. An article discussing the company’s proprietary technology reads: “PreveCeutical’s proprietary Sol-gel formulations begin as a liquid that is administrated into the nose, which then forms a gel as it is warmed in the nasal cavity where it can then be absorbed. This effectively bypasses the stomach and intestines – eliminating first pass metabolism – and may dramatically improve bioavailability, even compared to nasal sprays and newer delivery systems. This nose-to-brain delivery method offers numerous benefits, including fewer side effects and avoidance of unwanted rapid metabolism.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Health sciences company PreveCeutical Medical (PRVCF) is engineering a unique Sol-gel CBD-based technology delivery platform to provide direct, controlled pharmacological drug release. This technology could provide a clinical benefit for patients seeking relief for multiple medical indications including pain, inflammation, seizures and neurological disorders. An article discussing the company’s proprietary technology reads: “PreveCeutical’s proprietary Sol-gel formulations begin as a liquid that is administrated into the nose, which then forms a gel as it is warmed in the nasal cavity where it can then be absorbed. This effectively bypasses the stomach and intestines – eliminating first pass metabolism – and may dramatically improve bioavailability, even compared to nasal sprays and newer delivery systems. This nose-to-brain delivery method offers numerous benefits, including fewer side effects and avoidance of unwanted rapid metabolism.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)PreveCeutical Medical Inc. (PRVCF) Stock Research Links
Scroll down for more posts ▼